Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adam Johnson

Showing results (71-80 of 137) with videos related to

Pageof 14
Sort By:
Antimicrobial Agents and Chemotherapy|May 22, 2019
Pharmacodynamics of Tebipenem: New Options for Oral Treatment of Multidrug-Resistant Gram-Negative InfectionsLaura McEntee, Adam Johnson, Nicola Farrington, et al.
Mbio|August 24, 2017
Pharmacodynamics of the Orotomides against <i>Aspergillus fumigatus</i>: New Opportunities for Treatment of Multidrug-Resistant Fungal DiseaseWilliam W Hope, Laura McEntee, Joanne Livermore, et al.
Plos Pathogens|October 10, 2025
Lactic acid produced by optimal vaginal Lactobacillus spp. potently and specifically inactivates HIV-1 in vitro by targeting the viral RNA genome and reverse transcriptaseMuriel Aldunate, David Tyssen, Adam Johnson, et al.
Journal of the American College of Cardiology|November 17, 2022
Randomized Trials of Percutaneous Microaxial Flow Pump Devices: JACC State-of-the-Art ReviewMohit Pahuja, Adam Johnson, Ryan Kabir, et al.
Journal of Biomolecular Screening|September 24, 2011
Case studies of minimizing nonspecific inhibitors in HTS campaigns that use assay-ready platesYichin Liu, Maureen H Beresini, Adam Johnson, et al.
Antimicrobial Agents and Chemotherapy|April 8, 2020
Pharmacodynamics of Cefepime Combined with the Novel Extended-Spectrum-β-Lactamase (ESBL) Inhibitor Enmetazobactam for Murine Pneumonia Caused by ESBL-Producing <i>Klebsiella pneumoniae</i>Adam Johnson, Laura McEntee, Nicola Farrington, et al.
The Journal of Infectious Diseases|October 3, 2017
Pharmacodynamics of the Novel Antifungal Agent F901318 for Acute Sinopulmonary Aspergillosis Caused by Aspergillus flavusClara E Negri, Adam Johnson, Laura McEntee, et al.
Cureus|April 27, 2022
Medical Education Blog and Podcast Utilization During the COVID-19 PandemicPatrick E Boreskie, Teresa M Chan, Chris Novak, et al.
Antimicrobial Agents and Chemotherapy|November 1, 2021
A Combination of Amino Acid Mutations Leads to Resistance to Multiple Nucleoside Analogs in Reverse Transcriptases from HIV-1 Subtypes B and CPaul L Boyer, Catherine A Rehm, Michael C Sneller, et al.
JACC. Clinical Electrophysiology|June 6, 2024
Machine Learning of Cardiac Anatomy and the Risk of New-Onset Atrial Fibrillation After TAVRMark S Brahier, Shwetha Kochi, Julia Huang, et al.
Pageof 14

Showing results (71-80 of 137) with videos related to

Sort By:
Pageof 14
Antimicrobial Agents and Chemotherapy|May 22, 2019
Pharmacodynamics of Tebipenem: New Options for Oral Treatment of Multidrug-Resistant Gram-Negative InfectionsLaura McEntee, Adam Johnson, Nicola Farrington, et al.
Mbio|August 24, 2017
Pharmacodynamics of the Orotomides against <i>Aspergillus fumigatus</i>: New Opportunities for Treatment of Multidrug-Resistant Fungal DiseaseWilliam W Hope, Laura McEntee, Joanne Livermore, et al.
Plos Pathogens|October 10, 2025
Lactic acid produced by optimal vaginal Lactobacillus spp. potently and specifically inactivates HIV-1 in vitro by targeting the viral RNA genome and reverse transcriptaseMuriel Aldunate, David Tyssen, Adam Johnson, et al.
Journal of the American College of Cardiology|November 17, 2022
Randomized Trials of Percutaneous Microaxial Flow Pump Devices: JACC State-of-the-Art ReviewMohit Pahuja, Adam Johnson, Ryan Kabir, et al.
Journal of Biomolecular Screening|September 24, 2011
Case studies of minimizing nonspecific inhibitors in HTS campaigns that use assay-ready platesYichin Liu, Maureen H Beresini, Adam Johnson, et al.
Antimicrobial Agents and Chemotherapy|April 8, 2020
Pharmacodynamics of Cefepime Combined with the Novel Extended-Spectrum-β-Lactamase (ESBL) Inhibitor Enmetazobactam for Murine Pneumonia Caused by ESBL-Producing <i>Klebsiella pneumoniae</i>Adam Johnson, Laura McEntee, Nicola Farrington, et al.
The Journal of Infectious Diseases|October 3, 2017
Pharmacodynamics of the Novel Antifungal Agent F901318 for Acute Sinopulmonary Aspergillosis Caused by Aspergillus flavusClara E Negri, Adam Johnson, Laura McEntee, et al.
Cureus|April 27, 2022
Medical Education Blog and Podcast Utilization During the COVID-19 PandemicPatrick E Boreskie, Teresa M Chan, Chris Novak, et al.
Antimicrobial Agents and Chemotherapy|November 1, 2021
A Combination of Amino Acid Mutations Leads to Resistance to Multiple Nucleoside Analogs in Reverse Transcriptases from HIV-1 Subtypes B and CPaul L Boyer, Catherine A Rehm, Michael C Sneller, et al.
JACC. Clinical Electrophysiology|June 6, 2024
Machine Learning of Cardiac Anatomy and the Risk of New-Onset Atrial Fibrillation After TAVRMark S Brahier, Shwetha Kochi, Julia Huang, et al.
Pageof 14